Trial Profile
Comparative Effectiveness of Different Neuroprotectants Among Patients With Acute Ischemic Stroke in Clinical Practice
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Butylphthalide (Primary) ; Citicoline (Primary) ; Edaravone (Primary) ; FPF 1070 (Primary) ; Piracetam (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms CER
- 23 Mar 2012 New trial record